Point6 Bio
- Diagnostics
- Biotech or pharma, therapeutic R&D
Point6 Bio revolutionizes neurobiomarker discovery with an AI-driven multi-omics platform targeting dynamic protein changes and post-translational modifications. Validated in a POC study for autism, the technology is scalable to multiple indications.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}